Current concepts in the evaluation and treatment of neurofibromatosis type II
Brian A Neff1, D Bradley Welling
1Department of Otolaryngology, Mayo Clinic, Rochester, MN, USA.
Otolaryngologic Clinics of North America
|July 12, 2005
Abstract:
This article presents the current diagnostic and treatment options for the hereditary disease neurofibromatosis type II, reviews clinical presentation and diagnosis, highlights indications for and methods of clinical and genetic screening, discusses treatment approaches for surgery and stereotactic radiation, and summarizes potential future therapeutic avenues.
